Tlray Brands slipped about 3% today to US$3.59, even though the fresh quarter showed some of the cleanest progress this cannabis and beverage hybrid has reported in a while. Q1 revenue landed at US$257.1 million and gross profit reached US$77.5 million, while the business still posted a net loss of about US$40 million.
Short term traders focused on another losing quarter. Longer term investors will be weighing that loss against a low 0.5x P/S multiple, as well as management’s push toward higher margin international cannabis and beverage sales that frame the recovery story ahead.
Is Tilray Brands at 0.5x P/S a genuine recovery opportunity or just cheap for a reason? Compare the current market price to detailed cash flow and multiples work in our valuation analysis for Tilray Brands.Q1 2027 Earnings Summary
- Revenue (Q1 2027 vs. Q1 2026): US$257.1 million vs. US$209.5 million (higher top line for Tilray Brands year on year)
- Net Loss (Q1 2027 vs. Q1 2026): US$43.1 million loss vs. US$0.3 million loss (deeper quarterly loss)
- Basic EPS (Q1 2027 vs. Q1 2026): US$0.32 loss per share vs. US$0.00 loss per share (wider per share loss)
- Gross Profit and Margin (Q1 2027 vs. Q1 2026): Gross profit of US$77.5 million with roughly 30% consolidated gross margin vs. lower gross profit and margin in the prior year period
Prefer clean charts over extensive cannabis and beverage figures for Tilray Brands? See the full financial picture, including a clear view of valuation, in the visual company report for Tilray Brands.
Tilray Brands’ Recovery Story Meets Real Milestones
Bulls argue Tilray Brands can shift the mix toward higher margin international cannabis, beverages and wellness, and use that to rebuild profitability. Q1 gives some backing to that idea. International cannabis and CC Pharma distribution together showed healthy volume and revenue traction, while Portugal production costs fell sharply and Germany ran at full capacity. That is exactly the kind of upstream integration and medical expansion the optimistic story leans on.
On the beverage side, BrewDog moved into the black and helped lift segment gross margin to roughly 41%. That is a clear proof point that the beverage M&A playbook can produce better unit economics, not just more scale. The catch is that adjusted EBITDA stalled around US$9.2 million and the quarter still produced a US$40 million net loss, so the margin and mix milestones are landing before any broad earnings recovery shows up in the bottom line.
Compare Tilray Brands’ operational progress with analyst expectations and see whether recent margin and mix gains are changing the Street’s stance. Reveal the consensus price target analysis for Tilray Brands.Tliray Bears Still See Profitability Gap, Not Just Volatility
Bears argue Tilray Brands is stuck in a low quality mix where acquisitions, oversupply in cannabis and regulatory friction keep earnings and cash flow weak. Q1 does not fully disprove that. Consolidated revenue reached US$257.1 million and gross profit hit US$77.5 million, yet adjusted EBITDA slipped to US$9.2 million and the business still reported a GAAP net loss of about US$40 million. That gap between healthy scale and thin operating profit is the core concern.
Critics also worry integration will be slow and margin recovery uneven. BrewDog turned profitable and beverage gross margin improved to roughly 41%. At the same time, total cannabis net revenue eased to US$56.1 million, wellness margins took a temporary hit, and price compression in international cannabis created about US$8.8 million of pressure. With the share price down 3.49% today, the market reaction lines up more with missed profitability milestones than with a clean bear case rebuttal.
After another quarter where scale did not translate into strong earnings and shareholder dilution remained a concern, it is worth asking whether Tilray Brands’ weak profitability is a temporary execution issue or a sign of deeper structural pressure. Review the full risk analysis for Tilray Brands which shows 1 important warning sign.Take Control Of Your Next Move
If Tilray Brands’ low P/S ratio and widening loss make you want to watch how the story plays out before acting, register for free with Simply Wall St and add it to your Watchlist so you can track share price against fair value and wait for an entry point that fits your plan. After you decide to buy or trim a position, manage every holding in one view with the Portfolio Command Center that filters noise and highlights key changes that matter to your thesis. For longer term conviction, tap into thousands of investor views through the Community and see how others are thinking about risks, catalysts and position sizing. By spotting potential turning points and red flags early, you give yourself a better chance of staying ahead of the market instead of reacting after the fact.
Seeking Alternatives Beyond Tilray Brands?
Fresh ideas move first. Stocks gaining quiet momentum today can be flying or dropping by the time headlines catch up. Scan curated shortlists before the crowd and get in early.
- Spot resilient cash generators that could support steadier compounding and lower stress by reviewing the curated list of solid balance sheet and fundamentals stocks (25 results).
- Chase income opportunities while yields still look appealing by scanning hand picked 8 dividend fortresses before payout stories get fully priced in.
- Target AI exposure without betting on hype only by focusing on carefully filtered 35 profitable AI stocks that aren't just burning cash where revenue and profit already sit in the same conversation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com